In recent years, the sales of apixaban have grown rapidly, and the global market has already surpassed rivaroxaban. Because Eliquis (apixaban) has an advantage over warfarin in preventing stroke and bleeding, and Xarelto ( Rivaroxaban) only showed non-inferiority. In addition, Apixaban does not...
Read more